[HTML][HTML] Metformin ameliorates hepatic steatosis and inflammation without altering adipose phenotype in diet-induced obesity

SL Woo, H Xu, H Li, Y Zhao, X Hu, J Zhao, X Guo… - PloS one, 2014 - journals.plos.org
Non-alcoholic fatty liver disease (NAFLD) is closely associated with obesity and insulin
resistance. To better understand the pathophysiology of obesity-associated NAFLD, the …

Metformin ameliorates hepatic steatosis and inflammation without altering adipose phenotype in diet-induced obesity

SL Woo, H Xu, H Li, Y Zhao, X Hu, J Zhao… - PloS …, 2014 - augusta.elsevierpure.com
Non-alcoholic fatty liver disease (NAFLD) is closely associated with obesity and insulin
resistance. To better understand the pathophysiology of obesity-associated NAFLD, the …

[PDF][PDF] Metformin Ameliorates Hepatic Steatosis and Inflammation without Altering Adipose Phenotype in Diet

SL Woo, H Xu, H Li, Y Zhao, X Hu - 2014 - scienceopen.com
Non-alcoholic fatty liver disease (NAFLD) is closely associated with obesity and insulin
resistance. To better understand the pathophysiology of obesity-associated NAFLD, the …

[PDF][PDF] Metformin Ameliorates Hepatic Steatosis and Inflammation without Altering Adipose Phenotype in Diet

SL Woo, H Xu, H Li, Y Zhao, X Hu - 2014 - core.ac.uk
Non-alcoholic fatty liver disease (NAFLD) is closely associated with obesity and insulin
resistance. To better understand the pathophysiology of obesity-associated NAFLD, the …

Metformin ameliorates hepatic steatosis and inflammation without altering adipose phenotype in diet-induced obesity.

SL Woo, H Xu, HG Li, Y Zhao, X Hu, JJ Zhao, X Guo… - 2014 - cabidigitallibrary.org
Non-alcoholic fatty liver disease (NAFLD) is closely associated with obesity and insulin
resistance. To better understand the pathophysiology of obesity-associated NAFLD, the …

Metformin Ameliorates Hepatic Steatosis and Inflammation without Altering Adipose Phenotype in Diet-Induced Obesity

SL Woo, H Xu, H Li, Y Zhao, X Hu… - 1foldr Import 2019 …, 2014 - oaktrust.library.tamu.edu
Non-alcoholic fatty liver disease (NAFLD) is closely associated with obesity and insulin
resistance. To better understand the pathophysiology of obesity-associated NAFLD, the …

[PDF][PDF] Metformin Ameliorates Hepatic Steatosis and Inflammation without Altering Adipose Phenotype in Diet

SL Woo, H Xu, H Li, Y Zhao, X Hu - 2014 - pdfs.semanticscholar.org
Non-alcoholic fatty liver disease (NAFLD) is closely associated with obesity and insulin
resistance. To better understand the pathophysiology of obesity-associated NAFLD, the …

[PDF][PDF] Metformin Ameliorates Hepatic Steatosis and Inflammation without Altering Adipose Phenotype in Diet

SL Woo, H Xu, H Li, Y Zhao, X Hu - 2014 - Citeseer
Non-alcoholic fatty liver disease (NAFLD) is closely associated with obesity and insulin
resistance. To better understand the pathophysiology of obesity-associated NAFLD, the …

[HTML][HTML] Metformin Ameliorates Hepatic Steatosis and Inflammation without Altering Adipose Phenotype in Diet-Induced Obesity

SL Woo, H Xu, H Li, Y Zhao, X Hu, J Zhao, X Guo… - PLoS ONE, 2014 - ncbi.nlm.nih.gov
Non-alcoholic fatty liver disease (NAFLD) is closely associated with obesity and insulin
resistance. To better understand the pathophysiology of obesity-associated NAFLD, the …

Metformin ameliorates hepatic steatosis and inflammation without altering adipose phenotype in diet-induced obesity

SL Woo, H Xu, H Li, Y Zhao, X Hu, J Zhao… - PloS …, 2014 - pubmed.ncbi.nlm.nih.gov
Non-alcoholic fatty liver disease (NAFLD) is closely associated with obesity and insulin
resistance. To better understand the pathophysiology of obesity-associated NAFLD, the …